Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
BrightPath Biotherapeutics, The Current Fiscal Year Net Income Loss Widened in Downward Revision
BrightPath Biotherapeutics, Apr-Dec (Cumulative 3Q) Net Income Loss Narrows, Oct-Dec Net Income Loss Narrows
BrightPath Biotherapeutics Co., Ltd., First Half Net Income Loss Narrows, July-September Net Income Loss Narrows